VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,151,768 | -59.8% | 2,897,734 | +5.3% | 0.01% | -57.1% |
Q2 2023 | $67,499,593 | +5.5% | 2,751,716 | +0.1% | 0.03% | +3.7% |
Q1 2023 | $63,965,623 | +7.4% | 2,748,845 | +16.8% | 0.03% | 0.0% |
Q4 2022 | $59,576,171 | +32.4% | 2,353,859 | +0.8% | 0.03% | +22.7% |
Q3 2022 | $45,006,000 | -36.9% | 2,334,318 | -16.6% | 0.02% | -33.3% |
Q2 2022 | $71,330,000 | -10.3% | 2,800,537 | -9.4% | 0.03% | +6.5% |
Q1 2022 | $79,503,000 | -27.5% | 3,091,105 | +17.9% | 0.03% | -20.5% |
Q4 2021 | $109,731,000 | +18.0% | 2,620,753 | +22.6% | 0.04% | +5.4% |
Q3 2021 | $93,024,000 | -7.2% | 2,137,492 | +0.8% | 0.04% | -7.5% |
Q2 2021 | $100,282,000 | +8.7% | 2,121,026 | +17.9% | 0.04% | 0.0% |
Q1 2021 | $92,223,000 | +16.1% | 1,798,779 | -39.4% | 0.04% | +8.1% |
Q4 2020 | $79,451,000 | +11.2% | 2,966,806 | +42.5% | 0.04% | -2.6% |
Q3 2020 | $71,455,000 | -10.0% | 2,081,425 | +7.4% | 0.04% | -19.1% |
Q2 2020 | $79,436,000 | +10534.0% | 1,938,872 | +8793.9% | 0.05% | +4600.0% |
Q1 2020 | $747,000 | – | 21,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |